P. Vallance

发表

An Endothelium-Derived Hyperpolarizing Factor–Like Factor Moderates Myogenic Constriction of Mesenteric Resistance Arteries in the Absence of Endothelial Nitric Oxide Synthase–Derived Nitric Oxide

P. Vallance, A. Ahluwalia, S. Chauhan, 2001, Hypertension.

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases.

Ian G. Charles, I. Charles, P. Vallance, 1999, The Biochemical journal.

Measuring forearm blood flow and interpreting the responses to drugs and mediators.

P Vallance, D. Webb, P. Vallance, 1995, Hypertension.

Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

S. Moncada, P. Vallance, P. Vallance, 1991, The Lancet.

Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.

S. Moncada, P. Vallance, M. Radomski, 1993, Cardiovascular research.

Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo.

P. Vallance, J. Deanfield, N. Klein, 2001, Circulation.

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

S. Moncada, P. Vallance, A. Leone, 1992, The Lancet.

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases.

P. Vallance, J. Leiper, P. Vallance, 1999, Cardiovascular research.

Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS.

A. Hingorani, P. Vallance, K. Bhagat, 1999, Cardiovascular Research.

Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo.

P. Vallance, K. Bhagat, P. Vallance, 1997, Circulation.

Effects of guanidino and uremic compounds on nitric oxide pathways.

P. Vallance, R. Macallister, G. Whitley, 1994, Kidney international.

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

P. Vallance, A. Petros, D. Bennett, 1991, The Lancet.

Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo.

P Vallance, S. Moncada, P. Vallance, 1989, Cardiovascular research.

Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.

S. Moncada, P. Vallance, A. Calver, 1992, Journal of hypertension.

Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney.

P. Vallance, W. Welch, M. Omata, 1997, Kidney international.

Effects of ADMA upon gene expression : an insight into the pathophysiological significance of raised plasma ADMA

M. Hubank, P. Vallance, J. Leiper, 2005 .

Nitric oxide and cardiovascular control

P. Vallance, A. Calver, J. Collier, 1993, Experimental physiology.

Effects of a nitric oxide synthase inhibitor in humans with septic shock.

S. Moncada, P. Vallance, A. Leone, 1994, Cardiovascular research.

Nitric oxide takes centre-stage with newly defined roles.

T. McCall, P. Vallance, T. Mccall, 1992, Trends in pharmacological sciences.